BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 29024802)

  • 1. Synovial and systemic pharmacokinetics (PK) of triamcinolone acetonide (TA) following intra-articular (IA) injection of an extended-release microsphere-based formulation (FX006) or standard crystalline suspension in patients with knee osteoarthritis (OA).
    Kraus VB; Conaghan PG; Aazami HA; Mehra P; Kivitz AJ; Lufkin J; Hauben J; Johnson JR; Bodick N
    Osteoarthritis Cartilage; 2018 Jan; 26(1):34-42. PubMed ID: 29024802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a Single Intra-Articular Injection of a Microsphere Formulation of Triamcinolone Acetonide on Knee Osteoarthritis Pain: A Double-Blinded, Randomized, Placebo-Controlled, Multinational Study.
    Conaghan PG; Hunter DJ; Cohen SB; Kraus VB; Berenbaum F; Lieberman JR; Jones DG; Spitzer AI; Jevsevar DS; Katz NP; Burgess DJ; Lufkin J; Johnson JR; Bodick N;
    J Bone Joint Surg Am; 2018 Apr; 100(8):666-677. PubMed ID: 29664853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An intra-articular, extended-release formulation of triamcinolone acetonide prolongs and amplifies analgesic effect in patients with osteoarthritis of the knee: a randomized clinical trial.
    Bodick N; Lufkin J; Willwerth C; Kumar A; Bolognese J; Schoonmaker C; Ballal R; Hunter D; Clayman M
    J Bone Joint Surg Am; 2015 Jun; 97(11):877-88. PubMed ID: 26041848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and Systemic Exposure of Triamcinolone Acetonide Following Ultrasound-Guided Intra-Articular Injection of Triamcinolone Extended-Release or Standard Triamcinolone Acetonide in Patients with Shoulder Osteoarthritis: An Open-Label, Randomized Study.
    Hanson P; Kivitz A; Mehra P; Kwong L; Cinar A; Lufkin J; Kelley SD
    Drugs R D; 2021 Sep; 21(3):285-293. PubMed ID: 34350546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brief Report: A Phase IIb Trial of a Novel Extended-Release Microsphere Formulation of Triamcinolone Acetonide for Intraarticular Injection in Knee Osteoarthritis.
    Conaghan PG; Cohen SB; Berenbaum F; Lufkin J; Johnson JR; Bodick N
    Arthritis Rheumatol; 2018 Feb; 70(2):204-211. PubMed ID: 29088579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Triamcinolone Acetonide Extended-Release in Participants with Unilateral Knee Osteoarthritis: A Post Hoc Analysis.
    Langworthy MJ; Conaghan PG; Ruane JJ; Kivitz AJ; Lufkin J; Cinar A; Kelley SD
    Adv Ther; 2019 Jun; 36(6):1398-1411. PubMed ID: 30968336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triamcinolone acetonide extended-release in patients with osteoarthritis and type 2 diabetes: a randomized, phase 2 study.
    Russell SJ; Sala R; Conaghan PG; Habib G; Vo Q; Manning R; Kivitz A; Davis Y; Lufkin J; Johnson JR; Kelley S; Bodick N
    Rheumatology (Oxford); 2018 Dec; 57(12):2235-2241. PubMed ID: 30203101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local Effects Following Single and Repeat Intra-Articular Injections of Triamcinolone Acetonide Extended-Release: Results from Three Nonclinical Toxicity Studies in Dogs.
    Bodick N; Williamson T; Strand V; Senter B; Kelley S; Boyce R; Lightfoot-Dunn R
    Rheumatol Ther; 2018 Dec; 5(2):475-498. PubMed ID: 30203389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, phase IIa study to assess the systemic exposure of triamcinolone acetonide following injection of extended-release triamcinolone acetonide or traditional triamcinolone acetonide into both knees of patients with bilateral knee osteoarthritis.
    Kivitz A; Kwong L; Shlotzhauer T; Lufkin J; Cinar A; Kelley S
    Ther Adv Musculoskelet Dis; 2019; 11():1759720X19881309. PubMed ID: 31662801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained efficacy of a single intra-articular dose of FX006 in a rat model of repeated localized knee arthritis.
    Kumar A; Bendele AM; Blanks RC; Bodick N
    Osteoarthritis Cartilage; 2015 Jan; 23(1):151-60. PubMed ID: 25266960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physical and Chemical Compatibility of Extended-Release Triamcinolone Acetonide (TA-ER) with Common Local Anesthetics.
    Jackson JD; Cotton L; Turkington M; Leblanc D; Kelley S
    Adv Ther; 2019 Mar; 36(3):652-661. PubMed ID: 30706409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Randomized, Open-Label, Single-Dose Study to Assess Safety and Systemic Exposure of Triamcinolone Acetonide Extended-Release in Patients With Hip Osteoarthritis.
    Kivitz A; Mehra P; Hanson P; Kwong L; Cinar A; Lufkin J; Kelley S
    Rheumatol Ther; 2022 Apr; 9(2):679-691. PubMed ID: 35258839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved Treatment Effect of Triamcinolone Acetonide Extended-Release in Patients with Concordant Baseline Pain Scores on the Average Daily Pain and Western Ontario and McMaster Universities Osteoarthritis Index Pain Scales.
    Ross E; Katz NP; Conaghan PG; Kivitz A; Turk DC; Spitzer AI; Jones DG; Lanier RK; Cinar A; Lufkin J; Kelley SD
    Pain Ther; 2022 Mar; 11(1):289-302. PubMed ID: 34791634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triamcinolone Acetonide Extended-Release: A Review in Osteoarthritis Pain of the Knee.
    Paik J; Duggan ST; Keam SJ
    Drugs; 2019 Mar; 79(4):455-462. PubMed ID: 30847805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of triamcinolone acetonide following intramuscular and intra-articular administration to exercised Thoroughbred horses.
    Knych HK; Vidal MA; Casbeer HC; McKemie DS
    Equine Vet J; 2013 Nov; 45(6):715-20. PubMed ID: 23574452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of intra-articular triamcinolone preparations on blood glucose levels in diabetic patients: a controlled study.
    Habib GS; Miari W
    J Clin Rheumatol; 2011 Sep; 17(6):302-5. PubMed ID: 21869712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of intra-articular triamcinolone acetonide 10 mg vs. 40 mg in patients with knee osteoarthritis: a non-inferiority, randomized, controlled, double-blind, multicenter study.
    Utamawatin K; Phruetthiphat OA; Apinyankul R; Chaiamnuay S
    BMC Musculoskelet Disord; 2023 Feb; 24(1):92. PubMed ID: 36737698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and performance of Hydros and Hydros-TA for knee osteoarthritis: a prospective, multicenter, randomized, double-blind feasibility trial.
    Petrella RJ; Emans PJ; Alleyne J; Dellaert F; Gill DP; Maroney M
    BMC Musculoskelet Disord; 2015 Mar; 16():57. PubMed ID: 25887932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of Methylprednisolone Acetate Versus Triamcinolone Acetonide Intra-articular Knee Injection in Patients With Chronic Inflammatory Arthritis: A 24-Week Randomized Controlled Trial.
    Kumar A; Dhir V; Sharma S; Sharma A; Singh S
    Clin Ther; 2017 Jan; 39(1):150-158. PubMed ID: 28012569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine, catabolic enzyme and structural matrix gene expression in synovial fluid following intra-articular administration of triamcinolone acetonide in exercised horses.
    Knych HK; Vidal MA; Chouicha N; Mitchell M; Kass PH
    Equine Vet J; 2017 Jan; 49(1):107-115. PubMed ID: 26518341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.